Tecogen (TGEN) director Susan Hirsch granted stock options for 25,000 shares
Rhea-AI Filing Summary
TECOGEN INC. director Susan B. Hirsch received a compensation-related stock option grant covering 25,000 shares of common stock. The option has an exercise price of $5.17 per share and vests in equal 25% installments per year, providing potential future ownership if exercised. Following this award, Hirsch holds stock options for 25,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Hirsch Susan B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 25,000 | $5.17 | $129K |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,000 shares (Direct)
Footnotes (1)
- F1. Vests 25% per year
Key Figures
Option shares granted: 25,000 shares
Exercise price: $5.17 per share
Underlying common shares: 25,000 shares
+3 more
6 metrics
Option shares granted
25,000 shares
Stock Option (Right to Buy) granted to director on June 26, 2026
Exercise price
$5.17 per share
Conversion or exercise price of granted stock options
Underlying common shares
25,000 shares
Common stock underlying the stock option award
Post-grant option holdings
25,000 options
Total derivative securities following the reported transaction
Vesting schedule
25% per year
Footnote states the option vests 25% per year
Option expiration date
June 26, 2036
Expiration date of the stock option grant
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, vesting, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Grant, award, or other acquisition financial
"transaction code description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 5.1700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"Footnote: Vests 25% per year"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-26T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did TECOGEN INC. (TGEN) director Susan B. Hirsch report?
Susan B. Hirsch reported receiving a stock option grant for 25,000 shares of Tecogen common stock. The award is compensation-related and gives her the right, but not the obligation, to buy shares at a fixed exercise price in the future.
What is the exercise price of Susan B. Hirsch’s Tecogen (TGEN) stock options?
The granted stock options have an exercise price of $5.17 per share. This means Hirsch can buy Tecogen common stock at $5.17 per share once the options vest, regardless of the market price at that time.
How do Susan B. Hirsch’s Tecogen (TGEN) stock options vest over time?
The options vest at a rate of 25% per year, according to the filing footnote. This means the right to exercise the 25,000-share grant becomes available in four equal annual installments, aligning with common long-term incentive practices.
When do Susan B. Hirsch’s Tecogen (TGEN) stock options expire?
The options expire on June 26, 2036, as disclosed in the filing. If Hirsch does not exercise vested options by that expiration date, the right to buy Tecogen shares at $5.17 per share will lapse.
Did Susan B. Hirsch buy or sell Tecogen (TGEN) stock in the open market?
The filing reports a grant of stock options, not an open-market trade. Code “A” indicates a grant or award acquisition, so this is compensation rather than a market purchase or sale of Tecogen common shares.